Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrimidines >  Bromopyrimidine >  6-bromo-4-chlorothieno[3,2-d]pyrimidine

6-bromo-4-chlorothieno[3,2-d]pyrimidine

Basic information Safety Supplier Related

6-bromo-4-chlorothieno[3,2-d]pyrimidine Basic information

Product Name:
6-bromo-4-chlorothieno[3,2-d]pyrimidine
Synonyms:
  • 6-bromo-4-chlorothieno[3,2-d]pyrimidine
  • 6-broMo-4-chlorothieno[3,2-d]pyriMidine hcl
  • 4-Chloro-6-bromothieno[3,2-d]pyrimidine
  • Thieno[3,2-d]pyrimidine,6-bromo-4-chloro-
  • CML-008
  • 6-bromo-4-chlorothieno[3,2-d]pyrimidine ISO 9001:2015 REACH
  • KML-23
CAS:
225385-03-5
MF:
C6H2BrClN2S
MW:
249.52
EINECS:
635-520-2
Product Categories:
  • CHIRAL CHEMICALS
  • pyrimidine
  • Heterocycle-Pyrimidine series
Mol File:
225385-03-5.mol
More
Less

6-bromo-4-chlorothieno[3,2-d]pyrimidine Chemical Properties

Boiling point:
345.5±37.0 °C(Predicted)
Density 
1.955
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
form 
solid
pka
-0.19±0.40(Predicted)
Appearance
Off-white to light yellow Solid
InChI
InChI=1S/C6H2BrClN2S/c7-4-1-3-5(11-4)6(8)10-2-9-3/h1-2H
InChIKey
RJKAKJGOZXERRE-UHFFFAOYSA-N
SMILES
C1=NC(Cl)=C2SC(Br)=CC2=N1
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
25
Safety Statements 
45
RIDADR 
UN 2811 6.1 / PGIII
HazardClass 
IRRITANT
HS Code 
2934999090
More
Less

6-bromo-4-chlorothieno[3,2-d]pyrimidine Usage And Synthesis

Synthesis

16269-66-2

225385-03-5

General procedure for the synthesis of 6-bromo-4-chlorothieno[3,2-d]pyrimidines from 4-chlorothieno[3,2-d]pyrimidines: to dry 200 mL of tetrahydrofuran was added lithium diisopropylamine (25 mL, 61.54 mmol), and the reaction system was cooled to -78 °C. Subsequently, 4-chlorothieno[3,2-d] Pyrimidine (5 g, 39.30 mmol) was slowly added dropwise to the above mixture. After 20 min of reaction, 1,2-dibromo-1,1,2,2-tetrafluoroethane (11.45 g, 35.17 mmol) was slowly added. Stirring was continued at -78°C for 20 minutes, then gradually warmed to room temperature and continued for 2 hours. Upon completion of the reaction, water was added to the mixture and extracted with chloroform (3 x 300 mL), the organic phases were combined and dried over anhydrous magnesium sulfate. After concentration under reduced pressure, the mixture was developed with 200 mL of hexane to afford 6-bromo-4-chlorothieno[3,2-d]pyrimidine (6.5 g, 89.2% yield) as a dark brown solid. The product was characterized by 1H-NMR (400 MHz, CDCl3): δ 8.94 (s, 1H), 7.62 (s, 1H); LC-MS showed molecular ion peaks of 249 and 251 (MH+).

References

[1] MedChemComm, 2015, vol. 6, # 2, p. 339 - 346
[2] Journal of Medicinal Chemistry, 2015, vol. 58, # 14, p. 5522 - 5537
[3] Patent: US2013/72482, 2013, A1. Location in patent: Paragraph 0211; 0218; 0219
[4] Patent: US2007/99941, 2007, A1. Location in patent: Page/Page column 15
[5] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 1, p. 21 - 24

6-bromo-4-chlorothieno[3,2-d]pyrimidineSupplier

Shanghai Benso Pharmaceutical Technology Co., Ltd. Gold
Tel
15088289376
Email
248775804@qq.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
Shanghai Yuanding Chem. Sci. & Tech. Co., Ltd.
Tel
21-57721279
Email
sales@shydchem.com.cn
Shangchem Co., Ltd.
Tel
+86-21-68182121